CMMB - Why is Liver Disease Focused Chemomab Stock Trading Higher Today? | Benzinga
Chemomab Therapeutics Ltd (NASDAQ: CMMB) shares are trading higher after the FDA granted CM-101 Fast Track designation for adult patients of primary sclerosing cholangitis (PSC), a fibrotic liver disease.
Programs with Fast Track designation can benefit from early and more frequent interactions with the FDA during the clinical development ...